EMS Pharma EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals. | Cipla Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression, and cardiovascular diseases. | Sun Pharma Vensun Pharmaceuticals is a pharmaceutical company developing generic prescription products in various dosage forms. | Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. | ||
Founding Date | Founding Date 1978 | Founding Date 1964 | Founding Date 1935 | Founding Date 1983 | Founding Date 2017 |
Type | Type Public | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Bengaluru, IN HQ Bengaluru, IN Hyderabad, IN Visakhapatnam, IN Dublin, IE Kuala Lumpur, MY Puchong, MY see more | Locations BR HQ | Locations Mumbai, IN HQ South Melbourne, AU Mumbai, IN Nairobi, KE Cape Town, ZA Durban, ZA Durban, ZA see more | Locations Mumbai, IN HQ | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP |
Employees | Employees 16,315 | Employees 12,825 | Employees 27,764 | Employees 43,000 | Employees 8007% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) ₹142b (FY, 2024) | Revenue (est.) N/A | Revenue (est.) ₹254.5b (FY, 2024) | Revenue (est.) ₹477.6b (FY, 2024) | Revenue (est.) CHF152.4m (FY, 2023) |
Cost of goods | Cost of goods ₹50.9b (FY, 2024) | Cost of goods N/A | Cost of goods ₹88.2b (FY, 2024) | Cost of goods ₹114.4b (FY, 2024) | Cost of goods CHF7.2m (FY, 2023) |
Gross profit | Gross profit ₹102b (FY, 2024) | Gross profit N/A | Gross profit ₹169.5b (FY, 2024) | Gross profit ₹371.7b (FY, 2024) | Gross profit CHF146.4m (FY, 2023) |
Net income | Net income ₹13b (FY, 2024) | Net income N/A | Net income ₹41.6b (FY, 2024) | Net income ₹96.5b (FY, 2024) | Net income (CHF297.9m) (FY, 2023) |